Centene to Purchase WellCare in More Than $15 Billion Cash, Stock Deal

Centene to Purchase WellCare in More Than $15 Billion Cash, Stock Deal

Assessment

Interactive Video

Business, Social Studies

University

Hard

Created by

Wayground Content

FREE Resource

The transcript discusses a $17.3 billion deal involving WellCare and Centene, highlighting the 30% premium and market reactions. It explores the impact of government policies, particularly the Affordable Care Act, and the political landscape affecting healthcare. The discussion includes market strategies, the significance of Medicare Advantage, and regulatory challenges. The market's response to the deal is mixed, with WellCare shares rising and Centene shares falling, reflecting skepticism about Centene's M&A track record.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the value of the deal involving WellCare and Centene?

$10.5 billion

$25.7 billion

$30 billion

$17.3 billion

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is one of the main growth drivers for the health insurance industry mentioned in the transcript?

Medicare Advantage business

Government subsidies

Private health plans

Commercial insurance

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What political challenge is affecting the healthcare market according to the transcript?

Affordable Care Act repeal efforts

Rising healthcare costs

Lack of healthcare professionals

Increased competition from new entrants

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How did the market react to the merger between WellCare and Centene?

Both companies' shares decreased

Both companies' shares increased

Centene shares increased, WellCare shares decreased

WellCare shares increased, Centene shares decreased

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a potential reason for skepticism about Centene's merger execution?

High employee turnover

Previous losses from acquired policies

Lack of experience in mergers

Limited market presence